Form 4: United Therapeutics Director Tommy G. Thompson Exercises Stock Options and Sells Shares
SEC Form 4
Director Tommy G. Thompson exercised stock options and sold shares of United Therapeutics Corp on May 9, 2025.
Summary
- On May 9, 2025, Tommy G. Thompson, a director of United Therapeutics Corporation, exercised stock options to acquire 2,500 shares of common stock at a price of $175.43 per share.
- Simultaneously, Thompson sold 2,500 shares of common stock at a weighted average price of $305.146, with prices ranging from $305.05 to $305.55.
- Following these transactions, Thompson directly owns 8,480 shares of common stock and indirectly owns 8,200 shares through a trust and 5,800 shares through a family LLC.
- The exercised stock options were granted on June 26, 2016, and were set to expire on June 26, 2025.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock transactions. It doesn't convey any explicit positive or negative sentiment about the company's performance or future prospects.
Industry Context
This transaction is a routine disclosure of insider trading activity. It doesn't necessarily reflect a change in the company's outlook but rather the personal financial decisions of a company director.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership, but it is unlikely to be significant.
Key Dates
| Date | Description |
|---|---|
| 06/26/2016 | Date the stock options were granted. |
| 07/07/2023 | Date of vesting of RSUs for which the reporting person elected to defer receipt of shares. |
| 05/09/2025 | Date of stock option exercise and share sale. |
| 06/26/2025 | Expiration date of the stock options. |
| 07/08/2026 | Date of issuance of 880 shares of common stock as the result of the July 7, 2023 vesting of RSUs. |
Keywords
stock options, Form 4, UTHR, United Therapeutics, director, Tommy G. Thompson, share sale, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.